The market offers growth opportunities driven by increased demand for personalized medicine, advancements in cell and gene ...
QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
Rising API prices from China and feedstock disruptions amid the West Asia crisis are tightening cost pressures on India's ...
Lupin Manufacturing Solutions’ Dabhasa facility in India supports API development and commercial-scale manufacturing, forming ...
Key market opportunities include mastering API manufacturing complexities to ensure quality and compliance, navigating EU and USA regulatory frameworks, adhering to GMP and GDP standards, and adapting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results